Glenmede Trust’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Sell
25,501
-764
-3% -$10.7K ﹤0.01% 1100
2025
Q4
$327K Buy
+26,265
New +$283K ﹤0.01% 1105
2025
Q1
$187K Buy
21,488
+1,399
+7% +$14.7K ﹤0.01% 1220
2024
Q4
$250K Sell
20,089
-2,260
-10% -$27.8K ﹤0.01% 1166
2024
Q3
$259K Buy
22,349
+1,794
+9% +$20.7K ﹤0.01% 1151
2024
Q2
$218K Sell
20,555
-457
-2% -$5.05K ﹤0.01% 1163
2024
Q1
$251K Sell
21,012
-2,527
-11% -$30.4K ﹤0.01% 1106
2023
Q4
$255K Sell
23,539
-872
-4% -$8.35K ﹤0.01% 1077
2023
Q3
$241K Sell
24,411
-24,193
-50% -$252K ﹤0.01% 1056
2023
Q2
$468K Hold
48,604
﹤0.01% 850
2023
Q1
$468K Sell
48,604
-1,725
-3% -$19.1K ﹤0.01% 855
2022
Q4
$560K Sell
50,329
-9,478
-16% -$99K ﹤0.01% 811
2022
Q3
$509K Sell
59,807
-3,571
-6% -$35.1K ﹤0.01% 817
2022
Q2
$662K Sell
63,378
-4,128
-6% -$45.3K ﹤0.01% 779
2022
Q1
$734K Sell
67,506
-5,662
-8% -$74.6K ﹤0.01% 800
2021
Q4
$988K Sell
73,168
-60,499
-45% -$808K ﹤0.01% 749
2021
Q3
$1.81M Sell
133,667
-17,208
-11% -$244K 0.01% 561
2021
Q2
$2.15M Sell
150,875
-264,061
-64% -$3.82M 0.01% 525
2021
Q1
$5.79M Sell
414,936
-188,313
-31% -$3.07M 0.03% 377
2020
Q4
$11.3M Buy
603,249
+535,440
+790% +$8.73M 0.06% 311
2020
Q3
$1M Sell
67,809
-444
-0.7% -$7.09K 0.01% 619
2020
Q2
$1.1M Sell
68,253
-708,041
-91% -$11.5M 0.01% 589
2020
Q1
$15.6M Hold
776,294
0.07% 311
2019
Q4
$15.6M Buy
776,294
+765,137
+6,858% +$14.2M 0.07% 311
2019
Q3
$220 Buy
11,157
+8,912
+397% +$175K ﹤0.01% 1134
2019
Q2
$42 Sell
2,245
-983
-30% -$21.7K ﹤0.01% 1770
2019
Q1
$91 Sell
3,228
-19,846
-86% -$579K ﹤0.01% 1446
2018
Q4
$631 Buy
+23,074
New +$748K ﹤0.01% 809
2018
Q3
Sell
-18,261
Closed -$660K 1842
2018
Q2
$660K Sell
18,261
-4,151
-19% -$163K ﹤0.01% 783
2018
Q1
$947K Hold
22,412
﹤0.01% 790
2017
Q4
$947K Buy
22,412
+9,555
+74% +$365K ﹤0.01% 790
2017
Q3
$402K Sell
12,857
-823,314
-98% -$27.9M ﹤0.01% 966
2017
Q2
$32.6M Hold
836,171
0.16% 211
2017
Q1
$32.6M Buy
836,171
+234,843
+39% +$9.47M 0.16% 211
2016
Q4
$22.9M Sell
601,328
-19,708
-3% -$732K 0.12% 268
2016
Q3
$23.7M Buy
621,036
+105,498
+20% +$4.69M 0.13% 260
2016
Q2
$22.3M Sell
515,538
-292,007
-36% -$12.9M 0.14% 255
2016
Q1
$37.4M Buy
807,545
+396,326
+96% +$19.1M 0.24% 111
2015
Q4
$22.2M Sell
411,219
-412,785
-50% -$19.8M 0.15% 224
2015
Q3
$33.2M Buy
824,004
+206,338
+33% +$11.5M 0.24% 116
2015
Q2
$41.9M Sell
617,666
-229,982
-27% -$16.3M 0.3% 82
2015
Q1
$50.3M Buy
847,648
+197,933
+30% +$11.3M 0.37% 58
2014
Q4
$36.6M Buy
649,715
+337,872
+108% +$18.1M 0.29% 85
2014
Q3
$14.2M Buy
311,843
+39,935
+15% +$1.94M 0.12% 243
2014
Q2
$14M Buy
271,908
+48,339
+22% +$2.38M 0.13% 242
2014
Q1
$10.9M Buy
223,569
+3,733
+2% +$181K 0.1% 277
2013
Q4
$9.54M Sell
219,836
-239,787
-52% -$9.86M 0.1% 276
2013
Q3
$17.5M Buy
459,623
+14,809
+3% +$521K 0.21% 110
2013
Q2
$13.8M Buy
+444,814
New +$13.3M 0.17% 125

Other funds holding VTRS

Glenmede Trust's VTRS Position: Q1 2026 in Review

Glenmede Trust reduced its Viatris (VTRS) stake by 2.9% in Q1 2026, selling an estimated $10.7K and leaving 25,501 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Glenmede Trust first reported a position in VTRS in Q2 2013 and has held it in 49 quarters since. The position peaked at $50.3M in Q1 2015. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Glenmede Trust held 25,501 shares of Viatris worth $345K as of Q1 2026.
  • Glenmede Trust sold 764 Viatris shares in Q1 2026, an estimated $10.7K.
  • Viatris made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1100 holding.
  • Glenmede Trust first reported a position in Viatris in Q2 2013 and has held it in 49 quarters since.
  • Glenmede Trust's Viatris position peaked at $50.3M in Q1 2015.
  • 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.